Portal Diabetes, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500 (NCT07341373) | Portal Diabetes, Inc. | 2026-02-10 |
Track Portal Diabetes, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.